Yousif Capital Management LLC Has $6.45 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Yousif Capital Management LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 23,816 shares of the company’s stock after selling 1,321 shares during the quarter. Yousif Capital Management LLC’s holdings in HCA Healthcare were worth $6,447,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in HCA. Stone House Investment Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $25,000. BluePath Capital Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $27,000. Centerpoint Advisors LLC bought a new stake in HCA Healthcare during the 4th quarter worth approximately $27,000. Bruce G. Allen Investments LLC bought a new stake in HCA Healthcare during the 4th quarter worth approximately $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new position in shares of HCA Healthcare in the third quarter valued at approximately $30,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, SVP Chad J. Wasserman sold 652 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $312.04, for a total value of $203,450.08. Following the completion of the sale, the senior vice president now owns 290 shares of the company’s stock, valued at approximately $90,491.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at approximately $520,474. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,840 shares of company stock worth $4,588,869. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Down 1.5 %

Shares of NYSE:HCA opened at $314.12 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 35.07. The stock has a market capitalization of $83.08 billion, a P/E ratio of 16.55, a price-to-earnings-growth ratio of 1.54 and a beta of 1.65. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $335.83. The stock’s 50-day moving average price is $324.24 and its 200-day moving average price is $294.45.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The company had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same period last year, the firm earned $4.93 earnings per share. HCA Healthcare’s quarterly revenue was up 11.2% on a year-over-year basis. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 20.58 earnings per share for the current year.

HCA Healthcare announced that its Board of Directors has initiated a share repurchase plan on Tuesday, January 30th that allows the company to buyback $6.00 billion in shares. This buyback authorization allows the company to reacquire up to 7.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s payout ratio is 13.91%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on HCA shares. Barclays started coverage on HCA Healthcare in a report on Wednesday, March 6th. They issued an “overweight” rating and a $356.00 target price for the company. Raymond James upped their target price on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Oppenheimer reaffirmed an “outperform” rating and issued a $315.00 target price on shares of HCA Healthcare in a report on Wednesday, January 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a research note on Wednesday, April 10th. Finally, Royal Bank of Canada increased their target price on HCA Healthcare from $308.00 to $322.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Four analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $310.88.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.